CDC suggests ways to increase CRC screening rates

CDC suggests ways to increase CRC screening rates

(HealthDay)—Various approaches should be implemented to increase the use of colorectal cancer (CRC) screening tests, according to the November issue of the U.S. Centers for Disease Control and Prevention's Vital Signs.

Noting that CRC is the second leading cancer killer of U.S. men and women and that about 90 percent of people live five or more years when CRC is found early through testing, researchers from the CDC looked at ways to increase testing.

According to the report, about one in three adults (28 percent; 23 million) aged 50 to 75 years are not getting tested as recommended, and most of these adults (76 percent) are insured. To increase testing, should offer recommended test options ( test [FOBT], [FIT], and sigmoidoscopy), with information about each test; match patients with the tests they are most likely to complete; work with health professionals to increase testing via hiring and training of patient navigators; and create ways to make it easy to get FOBT/FIT kits in places other than the doctor's office.

"Testing saves lives, but only if people get tested. Studies show that people who are able to pick the test they prefer are more likely to actually get the test done. Increasing the use of all recommended tests can save more lives and is cost-effective," according to the report.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Hybrid screening strategy emerges for colorectal cancer

Aug 27, 2013

A strategy that combines two effective colorectal cancer screening methods, fecal immunological test and colonoscopy, may improve prevention and detection of colorectal cancer and reduce costs, according to a new study in ...

A recipe for increased colorectal cancer screening rates

Aug 14, 2012

Screening for colorectal cancer (CRC) is cost-effective and saves lives by early detection. The ability to screen large numbers of individuals is especially important for states with tight health insurance budgets dealing ...

Recommended for you

Survival differences seen for advanced-stage laryngeal cancer

Nov 27, 2014

The five-year survival rate for advanced-stage laryngeal cancer was higher than national levels in a small study at a single academic center performing a high rate of surgical therapy, including a total laryngectomy (removal ...

Gene test aids cancer profile

Nov 27, 2014

The first round of chemotherapy did little to suppress Ron Bose's leukemia. The second round, with 10 times the dose, knocked the proliferating blast cells down, but only by half.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.